With the improvements that had taken place, there will have been a $5/6 stock-price taken out of the equation. Risk level has dropped even though the price is up.

Has substantially lagged other defense stocks. An interesting turnaround story but short-term, doesn't expect great things. Nice dividend yield.

One of the few tech stocks that continues to trade at a reasonable multiple. They are in the process of acquiring Concorde EFS and will have to divest some operations sold in the near term, there will be some hiccups.

Valuation is getting a little high. Their pipeline is still a "show me" story.

Has been a lot of questions regarding the earnings quality. OK for a long-term value play. Would prefer others.

A quality company, but expensive. Pays a reasonable dividend. As safe investment.

Getting a little expensive. Would prefer to buy under $50.

Not cheap. Would like to see something fundamentally before getting interested at these levels.

Not a fan of North American auto manufacturers. A lot of pension concerns.

Trades at a very low multiple because of problems over the last few years. Volatile.

(A top pick Aug 22/03. Up 16%.) Sold their holdings, but still on their radar screen. If you own, hold.

(A top pick Aug 22/03. Up 9.5%.) Still likes at this price. Investors will start looking at this in the last half of 2004 because the company will start reaping the benefits in 2005. Good dividend.

(A top pick Aug 22/03. Up 22.5%.) Still likes. Have some good, new products. Would consider again at $35.

Generally are cautious on airlines. They have a tremendous amount of debt and very little equity value.

Prefers Freddie Mac as their accounting issues are behind him. Doesn't know what is in store for Fannie Mae.

Its drug coated stent is driving the price up, but other competitors are lurking on the horizon. Not cheap.

Hasn't performed very well for the last few years. Doesn't expect a whole lot of life. A sleepy stock. A lot of competition.

Priced quite high at this point. A great innovator. Expects their successful international growth story will continue.

Have a very good pipeline. Faces significant generic exposure for the next few years because of patent exposure. On his focus list and will probably stay there for some time.

A consumer driven stock. Getting a little expensive. May be a little bit of money left to make, but be cautious.

Longer-term, thinks there is a great amount of potential in this name. Trades by low some of its peers. And improving balance sheet.

Has been a laggard. Love the assets. Media stocks should do well with the election and Olympics this year. Good price.

Doesn't have the potential high growth of some other tech names.For a long-term perspective can grow the top line 8/9% and can still generate bottom-line growth in the mid teens range. Incredible balance sheet.

Pharmaceutical stocks are defensive in nature.In this environment, nobody's buying them.Will be dead money in the short term.The strongest of the drug companies and the deepest pipeline.A good price to buy out for the long-term.

Long-term outlook does not appear to be very good.Their costs are very high compared to similar companies because their work is done in-house.A lot of competition.Strong balance sheet.

Pharmaceutical stocks are defensive in nature.In this environment, nobody's buying them.Will be dead money in the short term.A good price to buy out for the long-term.

Not a fan for the short or long term.Quite a bit of leverage on the balance sheet.Pays a rich dividend relative to what it looks like its capable of.

A broken business model in a lot of ways.Close to $8 billion of debt repayments between 2004 and 2006.Not cheap.

Generic drug makers have been on quite a role.A good group to have exposure to.This company has FCC and business model problems.Risky.

No longer a high flier.Acquisitions used to fuel their growth.No longer have the balance sheet to make acquisitions.Will have decent growth, but nothing exciting.Not cheap.

Getting a little pricey.Growth has come from cost cutting and there's not a lot of room left for any more.Can't see how they can grow the top line.

There are still way too many companies in its sector and not enough buyers for its products.

Has turned into a momentum play.September 23 is going to be a big day when they will debut their 64-bit chip.An interesting bet but still a lot of"show me".Cheap on a price to sales basis.Put a tight stop loss on it.

Generates tremendous amounts of free cash flow, which bodes well for the dividend story.Focused on paying down debt.4% dividend.Wireless is producing top and bottom-line growth.

Generates tremendous amounts of free cash flow.Prefers Verizon.

Has been a laggard in this rally.As a big problem with earnings quality.On a valuation bases, it looks interesting.It might be of value trap.

Has a problem because of Wal-Mart's, etc. competition.Has an attractive valuation and a strong balance sheet.Treat as a trading stock.

Its closest competitor Loews has better stores and is user-friendlier.Story is improving.Has an attractive valuation.Good balance sheet.

This stock is on their focus list.Pretty attractively valued compared to its peers.Good earnings growth.

Investors had concerns on its lack of economic exposure and lower mortgage revenues compared to its peers.Earnings will probably come in better than expected.Buy for the 4% yield, earnings quality and growth.A good defensive stock.

Has been a laggard.Attractive valuation.Good exposure to an economic recovery in the latter half of the year.The power outage could be a wild card as they sell massive power generators.Under $30 is a good price.

Has had a tough year.The price war with McDonald's has now ended.Introducing new menus.Their Tim Horton's franchise has performed well throughout.Good price.